High-performance liquid chromatographic assay with fluorometric detection of ketanserin, a new antihypertensive agent and serotonin S2 antagonist in human plasma, blood and urine
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 272 (2) , 411-416
- https://doi.org/10.1016/s0378-4347(00)86149-6
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.BMJ, 1982
- The Antihypertensive Effects of Ketanserin (R 41 468), a Novel 5-Hydroxytryptamine-Blocking Agent, in Patients with Essential HypertensionClinical Science, 1981
- ACUTE BLOOD-PRESSURE-LOWERING EFFECT OF KETANSERINThe Lancet, 1981
- 5-HT2-RECEPTOR BLOCKADE IN THE TREATMENT OF HEART FAILUREThe Lancet, 1981
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- The Antihypertensive Effects of a Pure and Selective Serotonin-Receptor Blocking Agent (R 41 468) in Elderly PatientsAngiology, 1981
- Plethysmographic Registration of Volume Changes in a Hand Vein Effects of Serotonin and of a Specific AntagonistAngiology, 1980